Long-term use of bisphosphonates (BPs) has been associated with a specific type of tensile side femoral stress fracture known as Atypical Femoral Fracture (AFF). Theoretically periprosthetic femoral fractures (PFF) should be excluded from the diagnosis of AFF. However, emerging evidence correlates prolonged BPs use with the occurrence of a type of PFF with an atypical pattern (atypical PFF, APFF). The aim of the present study is to report 3 cases of APFF treated at a single centre.
Methods:
Clinical and radiographic records of PFF that occurred between January 2016 and August 2018 were retrospectively reviewed. All patients meeting the American Society for Bone and Mineral Research (ASBMR) criteria for definition of PFF were included. Management strategies for APFF and patient outcomes, including fracture healing and hip function (assessed by the Oxford Hip Score [OHS]) were collected.
Results:
3 patients in the study period were identified as APFF (1 incomplete, 2 complete). All patients were females with a mean age of 83.3 years. All patients were treated with lateral plating. The application of a contralateral strut allograft resulted in fracture healing in cases of complete fractures. Mean OHS at final follow-up was 34.3.
Conclusions:
Despite occurring around a hip stem like PFF, APFF had peculiar clinical and radiographic features, making them more similar to AFF. Therefore, the orthopaedic surgeon should also consider the natural history and healing problems associated with AFF prior in order to choose the most appropriate management for APFF.
AbdelMPWattsCDHoudekMT, et al. Epidemiology of periprosthetic fracture of the femur in 32 644 primary total hip arthroplasties: a 40-year experience. Bone Joint J2016; 98–B: 461–467.
3.
MarslandDMearsSC. A review of periprosthetic femoral fractures associated with total hip arthroplasty. Geriatr Orthop Surg Rehabil2012; 3: 107–120.
4.
ThienTMChatziagorouGGarellickG, et al. Periprosthetic femoral fracture within two years after total hip replacement: analysis of 437,629 operations in the Nordic arthroplasty register association database. J Bone Joint Surg Am2014; 96: e167.
5.
JakubowitzESeegerJBKretzerJP, et al. The influence of age, bone quality and body mass index on periprosthetic femoral fractures: a biomechanical laboratory study. Med Sci Monit2009; 15: BR307–BR312.
6.
CatanachMJMSorialRMEslickGD. Thirteen-year outcomes in the Anatomique Benoist Girard II hip prosthesis. ANZ J Surg2015; 85: 255–259.
7.
ZhaoXHuDQinJ, et al. Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis. J Orthop Surg2015; 10: 65.
8.
NagoyaSTatedaKOkazakiS, et al. Restoration of proximal periprosthetic bone loss by denosumab in cementless total hip arthroplasty. Eur J Orthop Surg Traumatol2018; 28: 1601–1607.
9.
TarantinoUIolasconGCianferottiL, et al. Clinical guidelines for the prevention and treatment of osteoporosis: summary statements and recommendations from the Italian Society for Orthopaedics and Traumatology. J Orthop Traumatol2017; 18: 3–36.
10.
CaggiariGLealiPTMoseleGR, et al. Safety and effectiveness of teriparatide vs alendronate in postmenopausal osteoporosis: a prospective non randomized clinical study. Clin Cases Miner Bone Metab2016; 13: 200–203.
11.
IolasconGNapolanoRGioiaM, et al. The contribution of cortical and trabecular tissues to bone strength: insights from denosumab studies. Clin Cases Miner Bone Metab2013; 10: 47–51.
12.
ToroGOjeda-ThiesCCalabròG, et al. Management of atypical femoral fracture: a scoping review and comprehensive algorithm. BMC Musculoskelet Disord2016; 17: 227.
13.
ShaneEBurrDAbrahamsenB, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res2014; 29: 1–23.
14.
TeoBJKohJSGohSK, et al. Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy. Bone Joint J2014; 96–B: 658–664.
15.
PrasarnMLAhnJHelfetDL, et al. Bisphosphonate-associated femur fractures have high complication rates with operative fixation. Clin Orthop Relat Res2012; 470: 2295–2301.
16.
WeilYARivkinGSafranO, et al. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use. J Trauma2011; 71: 186–190.
17.
OdvinaCVZerwekhJERaoDS, et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab2005; 90: 1294–1301.
18.
UnnanuntanaASalehAMensahKA, et al. Atypical femoral fractures: what do we know about them?: AAOS exhibit selection. J Bone Joint Surg Am2013; 95: e81–13.
19.
Robinson JdeDLeightonRKTraskK, et al. Periprosthetic atypical femoral fractures in patients on long-term bisphosphonates: a multicenter retrospective review. J Orthop Trauma2016; 30: 170–176.
20.
LeeYKParkCHKimKC, et al. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty. Injury2018; 49: 2264–2268.
21.
CurtinBMFehringTK. Bisphosphonate fractures as a cause of painful total hip arthroplasty. Orthopedics2011; 34: e939–e944.
22.
ChenFLiRLallA, et al. Atypical Vancouver type-C periprosthetic fracture complicated by nonunion: a case report. JBJS Case Connect2015; 5: e44.
23.
CrossMBNamDvan der MeulenMC, et al. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. J Bone Joint Surg Br2012; 94: 994–997.
24.
Moya-AngelerJZambranaLWestrichGH, et al. Atypical femoral fracture post total hip replacement in a patient with hip osteoarthritis and an ipsilateral cortical thickening. Hip Int2016; 26: e19–e23.
25.
LeeKJMinBWJangHK, et al. Periprosthetic atypical femoral fracture-like fracture after hip arthroplasty: a report of three cases. Hip Pelvis2015; 27: 187–191.
26.
NiikuraTLeeSYSakaiY, et al. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report. J Med Case Rep2015; 9: 103.
27.
LeclercJMichouLVaillancourtF, et al. Prevalence and characteristics of atypical periprosthetic femoral fractures. J Bone Miner Res2019; 34: 83–92.
28.
MiuraTKijimaHTaniT, et al. Two cases of periprosthetic atypical femoral fractures in patients on long-term bisphosphonate treatment. Case Rep Surg2019; 2019: 9845320.
29.
TanakaSFukuiTOeK, et al. A periprosthetic femoral fracture with characteristics of atypical femoral fracture. Case Rep Orthop2019; 2019: 1275369.
30.
BottaiVDe PaolaGCelliF, et al. Histological study of atraumatic periprosthetic fractures: does atypical periprosthetic fracture exist?Clin Cases Miner Bone Metab2017; 14: 136–139.
31.
WooSBChoiSTChanWL. Atypical periprosthetic femoral fracture: a case report. J Orthop Surg (Hong Kong)2016; 24: 269–272.
32.
SoenenMMigaudHBonnometF, et al. Interprosthetic femoral fractures: analysis of 14 cases. Proposal for an additional grade in the Vancouver and SoFCOT classifications. Orthop Traumatol Surg Res2011; 97: 693–698.
33.
DrippsRDLamontAEckenhoffJE. The role of anesthesia in surgical mortality. JAMA1961; 178: 261–266.
34.
ToroGBothorelHSaffariniM, et al. Uncemented total hip arthroplasty in octogenarian and nonagenarian patients. Eur J Orthop Surg Traumatol2019; 29: 103–110.
35.
YeungYChiuKYYauWP, et al. Assessment of the proximal femoral morphology using plain radiograph-can it predict the bone quality?J Arthroplasty2006; 21: 508–513.
KhanujaHSVakilJJGoddardMS, et al. Cementless femoral fixation in total hip arthroplasty. J Bone Joint Surg Am2011; 93: 500–509.
38.
VerdonschotN. Philosophies of stem designs in cemented total hip replacement. Orthopedics2005; 28(Suppl. 8): s833–s840.
39.
DijkmanBGSpragueSSchemitschEH, et al. When is a fracture healed? Radiographic and clinical criteria revisited. J Orthop Trauma2010; 24(Suppl. 1): S76–S80.
40.
LindahlHMalchauHHerbertsP, et al. Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register. J Arthroplasty2005; 20: 857–865.
41.
KhatodMInacioMCSDellRM, et al. Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry. Clin Orthop Relat Res2015; 473: 3412–3420.
42.
SchilcherJSandbergOIsakssonH, et al. Histology of 8 atypical femoral fractures: remodeling but no healing. Acta Orthop2014; 85: 280–286.
43.
AdamsALAdamsJLRaebelMA, et al. Bisphosphonate drug holiday and fracture risk: a population-based cohort study. J Bone Miner Res2018; 33: 1252–1259.
44.
SolarinoGPiazzollaAMoriCM, et al. Alumina-on-alumina total hip replacement for femoral neck fracture in healthy patients. BMC Musculoskelet Disord2011; 12: 32.
45.
Al SubaieAEmamiETamimiI, et al. Systemic administration of omeprazole interferes with bone healing and implant osseointegration: an in vivo study on rat tibiae. J Clin Periodontol2016; 43: 193–203.
46.
CarliAVNegusJJHaddadFS. Periprosthetic femoral fractures and trying to avoid them: what is the contribution of femoral component design to the increased risk of periprosthetic femoral fracture?Bone Joint J2017; 99–B: 50–59.
47.
EdwardsBJBuntaADLaneJ, et al. Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events and Reports (RADAR) project. J Bone Joint Surg Am2013; 95: 297–307.
48.
FrobergLTroelsenABrixM. Periprosthetic Vancouver type B1 and C fractures treated by locking-plate osteosynthesis: fracture union and reoperations in 60 consecutive fractures. Acta Orthop2012; 83: 648–652.
49.
ToroGLeporeFCalabròG, et al. Humeral shaft non-union in the elderly: results with cortical graft plus stem cells. Injury2019; 50(Suppl. 2): S75–S79.
50.
KanakeshwarRBJayaramarajuDAgraharamD, et al. Management of resistant distal femur non-unions with allograft strut and autografts combined with osteosynthesis in a series of 22 patients. Injury2017; 48(Suppl. 2): S14–S17.
51.
HaddadFSDuncanCPBerryDJ, et al. Periprosthetic femoral fractures around well-fixed implants: use of cortical onlay allografts with or without a plate. J Bone Joint Surg Am2002; 84: 945–950.
52.
LealiPTBalsanoMMaestrettiG, et al. Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study. Clin Cases Miner Bone Metab2017; 14: 153–156.
53.
YehW-LSuC-YChangC-W, et al. Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment. BMC Musculoskelet Disord2017; 18: 527.
54.
ManaraJRMathewsJASandhuHS. Cable plating with a single strut allograft in the treatment of periprosthetic fractures of the femur. Hip Int2019; 29: 58–64.
